Verrica Pharmaceuticals Inc. ·
VRCA 8-K 2026-08-06
Verrica Pharmaceuticals Inc. (VRCA) 8-K dated 2026-08-06 — accession 0001193125-26-338273. This URL is the filing, not the VRCA hub.
Verrica Pharmaceuticals Inc. (VRCA) is a biotechnology company listed on US.
Verrica Pharmaceuticals Inc. filed a 8-K on 2026-08-06. Accession 0001193125-26-338273.
Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
Not investment advice. The VRCA SEC hub lists recent forms. The stock page is the research view.